The FDA has approved Novartis’ Diovan HCT (valsartan/hydrochlorothiazide tablets) and Exforge (amlodipine/valsartan tablets) as first-line therapies for hypertension in patients likely to need ...

Exforge HCT contains amlodipine, a calcium channel blocker, valsartan, an angiotensin II receptor blocker, ... 10mg/160mg/25mg, and 10mg/320mg/25mg strengths in 30- and 90-count bottles. ...